Società medicina migrazioni, tra loro minore incidenza ma è allerta prevenzione
Risultati per: Nanotubi di DNA per terapie contro i tumori del cervello
Questo è quello che abbiamo trovato per te
Tumori, gli organoidi-avatar per testare l'efficacia dei farmaci
Regina Elena, primi 2 casi clinici.A pazienti le cure più mirate
Tumori neuroendocrini, nuova terapia riduce rischio progressione
In aumento, un terzo dei pazienti riceve diagnosi dopo 5 anni
Tumori neuroendocrini, nuova terapia riduce rischio progressione
In aumento, un terzo dei pazienti riceve diagnosi dopo 5 anni
How DNA Sensing Drives Inflammation
New England Journal of Medicine, Ahead of Print.
Ast Pesaro-Urbino, visite gratuite per prevenire tumori
Prenotazioni aperte a Fano il 18 settembre
SPECIALE ESMO – L'immunoterapia aumenta la sopravvivenza in un numero crescente di tumori
Dal melanoma al seno. Da studiare il fenomeno della resistenza in certi pazienti
Immunoterapia e farmaci mirati contro i tumori ginecologici
Tra principali cause di morte. Funzionano le combinazioni
Cohort profile: DNA methylation in the Northern Ireland Cohort for the Longitudinal Study of Ageing (NICOLA) – recruitment and participant characteristics
Purpose
Epigenetic modifications including DNA methylation (DNAm) are proposed mechanisms by which social or environmental exposures may influence health and behaviours as we age. The Northern Ireland Cohort for the Longitudinal Study of Ageing (NICOLA) DNAm cohort, established in 2013, is one of several worldwide, nationally representative prospective studies of ageing with biological samples from participants who consented to multiomic analysis.
Participants
NICOLA recruited 8478 participants (8283 aged 50 years or older and 195 spouses or partners at the same address aged under 50 years). Computer-Assisted Personal Interviews, Self-Completion Questionnaires and detailed Health Assessments (HA) were completed. Of the 3471 (44.1%) participants who attended the HA in wave 1, which included venous blood sampling, 2000 were identified for the DNAm cohort. Following technical and data quality control checks, DNAm data are currently available for n=1870.
Findings to date
There was no significant difference based on age, self-reported gender, education, employment, smoking or alcohol status and subjective health reports between the DNAm cohort and other HA attendees. Participants were more likely to be in the DNAm group if they lived with one other person (OR 1.26, 95% CI 1.07 to 1.49). The DNAm group had a lower proportion of depressed participants and those meeting criteria for post-traumatic stress disorder (11.7% and 4.4% vs 13.5% and 4.5%, respectively) categorised by objective assessment tools but this was not significant (OR 0.84, 95% CI 0.69 to 1.02 and OR 0.87, 95% CI 0.64 to 1.19).
Future plans
The deeply phenotyped DNAm cohort in NICOLA with planned prospective follow-up and additional multiomic data releases will increase the cohort’s utility for research into ageing. The genomic and epigenetic data for the DNAm cohort has been deposited on the European Genome-Phenome Archive, increasing the profile of this cohort and data availability to researchers.
Virus delle zecche scoperto in Cina, può colpire il cervello
Lo rivela una ricerca sul New England Journal of Medicine
>>>ANSA/Cure innovative tumori,in Italia oltre un anno di attesa
Oncologi, “troppa burocrazia, abolire i Prontuari regionali”
Tumori, in 35 anni 6 milioni vite salvate in Ue grazie a ricerca
Aiom, ‘in Italia evitate 270mila morti dal 2007 al 2019’
Covid e lockdown hanno fatto invecchiare il cervello dei ragazzi
4,2 anni in più per le femmine, 1,4 per i maschi
Padova realizzerà modelli statistici sui tumori al polmone
Incarico all’Università del valore di 3 milioni di dollari
Al Candiolo la Biobanca con 128 mini-tumori creati in laboratorio
Per neoplasia colon-retto. Si studiano nuove cure personalizzate
'I telefoni cellulari non sono collegati al cancro al cervello'
Lo ribadisce il più grande studio condotto, incaricato dall’Oms